Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis

Published:2010-06-01 Issue:6 Volume:67 Page:
ISSN:0003-9942
Container-title:Archives of Neurology
language:en
Short-container-title:Arch Neurol

Author:

Piccio Laura,Naismith Robert T.,Trinkaus Kathryn,Klein Robyn S.,Parks Becky J.,Lyons Jeri A.,Cross Anne H.

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology,Arts and Humanities (miscellaneous)

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis;Clinical Immunology;2024-07

2. Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis;Journal of Neuroinflammation;2024-04-12

3. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis;JAMA Neurology;2024-04-01

4. Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab;European Thyroid Journal;2024-03

5. Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion;Neurologic Clinics;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP